Miravo Healthcare Mergers and Acquisitions Summary

Healthcare ServicesCompany

Miravo Healthcare has acquired 3 companies of its own, including 3 in the last 5 years. It has also divested 1 asset.

Miravo Healthcare’s largest acquisition to date was in 2018, when it acquired Aralez Pharmaceuticals - Commercial Products & Infrastructure Pharmaceutical Business for $110M. It’s largest disclosed sale occurred in 2014, when it sold Nuvo Research - PENNSAID to Horizon Therapeutics Public Limited Company for $45M. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Miravo Healthcare’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity3
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Miravo Healthcare

Nuvo Pharmaceuticals, Inc.

6733 Mississauga Road, Suite 610,
Mississauga, Ontario L5N 6J5
Canada,
(905) 673-6980
www.miravohealthcare.com

Miravo Healthcare is a specialty pharmaceutical company with a diverse portfolio of products and technologies. Miravo Healthcare was founded in 1983 and is based in Mississauga, Canada.


M&A Summary

Buy vs Sell

Year ≤ '18 '19 '20 '21 '22 '23 T
Buy (0.0/yr) # 3 - - - - - 3
vol $330M $330M
Sell (0.0/yr) # 1 - - - - - 1
vol $45M $45M
  4

Most Recent M&A

Company Date Value Type
Aralez Pharmaceuticals, Inc. - Commercial Products & Infrastructure Pharmaceutical Business 2018-09-19 110M USD Divestiture
Milton, Ontario
Aralez Pharmaceuticals, Inc. - VIMOVO Royalties 2018-08-10 110M USD Divestiture
Milton, Ontario · www.vimovo.com
Aralez Pharmaceuticals, Inc. 2018-08-10 110M USD Add-on Acquisition
Milton, Ontario · www.aralez.com
Nuvo Research - PENNSAID 2014-10-17 45M USD Divestiture
, United States
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Aralez Pharmaceuticals, Inc. 2018-08-10 Aralez Pharmaceuticals, Inc. - Commercial Products & Infrastructure Pharmaceutical Business 2018-09-19 2
Milton, Ontario · www.aralez.com Milton, Ontario
Aralez Pharmaceuticals, Inc. 2018-08-10 Aralez Pharmaceuticals, Inc. - VIMOVO Royalties 2018-08-10 1
Milton, Ontario · www.aralez.com Milton, Ontario · www.vimovo.com

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 330M (100%) 1 (100%) 45M (100%)
Total 3 $330M 1 $45M

By Geo

State/Country Buy Value Sell Value
Canada 3 330M - -
  Ontario 3 330M - -
United States - - 1 45M
Domestic 3 (100%) 330M (100%) - -
Cross-border - - 1 (100%) 45M (100%)
Total 3 $330M 1 $45M

Deal Values

buy # Total
$100M to $1B 3 $330M
TOTAL $330M
Largest Aralez Pharmaceuticals, Inc. - Commercial Products & Infrastructure Pharmaceutical Business
$110M (2018-09-19)
sell # Total
< $100M 1 $45M
TOTAL $45M
Largest Nuvo Research - PENNSAID
$45M (2014-10-17)

M&A Connections

Deals
Acquired from
Strategic(s)
67%
2 (67%)
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 187,340
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.4K Private Equity Firms
  • 178K M&A Transactions
  • 183K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 68K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.